The MedChannel is an educational resource for you. See the latest medical information from thought leaders at Wake Forest Baptist Health. View educational videos, presentations, symposia and surgeries. See new technology and approaches to patient care. Watch for CME programs. Click here to receive monthly updates on featured content.

Important Links

Featured Videos

Robotic-Assisted Surgery: Lung Resection Video

Robotic-Assisted Surgery: Lung Resection

Watch as Dr. L. James Wudel, Jr., performs a minimally-invasive lung resection of right upper lobe cancer. His unique approach results in less trauma, less pain, and faster recovery for patients.

Minimally Invasive Posterior Approach Hip Video

Minimally Invasive Posterior Approach Hip

John Shields, MD, Assistant Professor of Orthopedics, discusses a new technique in minimally invasive posterior hip surgery.

MAST MIDLIF: A Hybrid Minimally Invasive Posterior Interbody Fusion Technique with Cortical Bone Screws Video

MAST MIDLIF: A Hybrid Minimally Invasive Posterior Interbody Fusion Technique with Cortical Bone Screws

Dr. Charles Branch Jr, professor and chair of the Department of Neurosurgery at Wake Forest Baptist Medical Center, discusses the use of cortical bone screws in multiple minimally invasive fusion procedures.

Celiac Disease - The great masquerader Video

Celiac Disease - The great masquerader

Anca M. Safta, MD, discusses her topic of Celiac Disease

News Releases

Seven Wake Forest Baptist Specialties Earn Top-50 Rankings in U.S. News & World Report’s Annual ‘Best Hospitals’ Survey

Tuesday, August 14, 2018 9:45 AM

Seven Wake Forest Baptist Medical Center specialties have earned top-50 rankings from U.S. News & World Report in its 2018-19 “Best Hospitals” survey. This marks the 26th consecutive year that Wake Forest Baptist programs have been ...

Scientists Identify Genetic Marker for Gastric Cancer Prognosis

Thursday, August 9, 2018 11:05 AM

Although immunotherapy is seen as a very promising treatment for cancer, currently only 20 to 30 percent of patients respond positively. Being able to identify the people most likely to benefit from the costly therapy is a Holy Grail for oncologists.

View More